News

Sofwave Medical's Upcoming Conferences and Innovations

Sofwave Medical's Upcoming Conferences and Innovations

Sofwave Medical's Participation in Key Conferences

Exciting times are ahead for Sofwave Medical Ltd, a trailblazer in non-invasive aesthetic medical devices. The company's leadership, including CEO Louis Scafuri and CFO Assaf Korner, are gearing up to showcase their innovations at two significant conferences. These gatherings present a great opportunity for industry interaction and networking while highlighting the company’s cutting-edge technologies.

Upcoming Conference Details

The 24th Annual Needham Virtual Healthcare Conference, a prominent event in the healthcare industry, will feature Sofwave’s corporate overview presentation. Scheduled for a convenient Wednesday morning, attendees can tune in on April 9, 2025, at 9:30 a.m. ET. This session promises insights into the company's operations and innovations.

Additionally, Sofwave will engage in one-on-one discussions during the Wells Fargo 2025 Virtual Private MedTech Symposium also occurring on April 9, 2025. This format allows for focused conversations that can foster valuable connections.

About Sofwave Medical Ltd

Sofwave Medical Ltd stands at the forefront of aesthetic technology with its revolutionary SUPERB™ technology. This FDA-cleared system employs Synchronous Ultrasound Parallel Beam technology to effectively improve facial lines, lift eyebrows, and address skin laxity. It’s also designed to enhance the appearance of cellulite and treat acne scars.

Innovative Technologies Transforming Aesthetic Medicine

The company’s groundbreaking technologies do not stop there. The Pure Impact™ module incorporates 4th generation EMS technology, providing non-invasive muscle toning solutions that are both effective and safe for patients. This advancement empowers physicians with reliable tools for enhancing their patients' aesthetic appearance while ensuring comfort during procedures.

With a commitment to innovation, Sofwave continually seeks to develop smart, user-friendly devices that provide consistent results. These efforts are a part of the company’s strategy to meet the rising demand for non-surgical aesthetic enhancements, making them a leader in this competitive market.

Investing in Future Growth

Sofwave Medical's achievements and active participation in industry conferences signify not just their current success but their proactive approach to future growth. Investors and industry enthusiasts alike are encouraged to follow their journey as they expand their presence in the aesthetic space. The company’s stock (TASE: SOFW) reflects this positive momentum, making it an intriguing choice for investors interested in technological advancements in healthcare.

Connecting with Sofwave Medical

For any inquiries or further information about their innovative products, the team at Sofwave can be reached via email. They prioritize communication and look forward to engaging with both current and prospective clients. Those interested in investor relations can connect with Brian Ritchie from LifeSci Advisors, ensuring effective dialogue for those looking into investment opportunities.

As Sofwave Medical endeavors into these conferences, they continue to set standards in the aesthetic device industry, driving trends and inspiring confidence in patient care.

Frequently Asked Questions

1. What is the purpose of the conferences Sofwave Medical is attending?

Sofwave Medical aims to showcase its innovative products and engage in meaningful discussions within the healthcare sector.

2. What technologies does Sofwave Medical specialize in?

The company focuses on non-invasive technologies for wrinkle reduction, lifting, and improving skin laxity, leveraging their SUPERB™ technology.

3. How can investors learn more about Sofwave Medical?

Investors can follow their developments via industry news and should reach out to the investor contact for further inquiries.

4. Are Sofwave Medical products FDA-cleared?

Yes, Sofwave Medical's products, including SUPERB™, are FDA-cleared, signifying their safety and efficacy.

5. What should I expect from the Needham Virtual Healthcare Conference?

Attendees can expect a corporate overview of Sofwave Medical, detailing their technological advancements, clinical results, and market impact.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

TLC Jet Teams Up with WIMCO St. Barth Properties

Updated Category News Views 5

Setting the Jet Set Stage Aflame In the ever-glam world of high-end travel, TLC Jet, out of Fort Lauderdale, has just inked a deal with WIMCO St. Barth Properties. Look, if you've got a penchant for island hopping or sipping your cocktail with sand between your toes, this aligns perfectly with your luxury cravings. This duo isn't just whispering sweet nothings in the...

Continue Reading
Csquare Investors Face Tough Questions Amid Probe

Updated Category News Views 55

Csquare's Shaky Claims and Market Consequences When a company flashes big numbers like $356 million to showcase its financial health, it sure gets the ticker NYSE:CSQR buzzing. But here's the rub—over half of that is locked up tighter than a drum, off-limits for general use. You gotta appreciate the irony, right? Someone's turned up a rock and there it is, a mess of...

Continue Reading
Astra Security Tackles PHP2Shell Vulnerabilities Head-On

Updated Category News Views 26

Unlocking the PHP Puzzle Hot off the press, Astra Security's stepping up to the plate with some freebie tools designed to sniff out and stamp out those pesky PHP2Shell vulnerabilities—CVE-2026-109618 and CVE-2026-109619. If you're not familiar, these suckers rate a whopping 9.2 on the CVSS v4.0 scale, and that means they got the potential to let remote code execution...

Continue Reading
Americas Cardroom Smashes Prize Pools; Bahamas Up Next

Updated Category News Views 49

Ah, poker. Where dreams are won with a flick of the wrist and a well-placed bluff. This week, it was all eyes on Americas Cardroom’s Dual Venom PKOs, and let me tell you, they didn't just meet expectations—they chewed them up and spat them out like yesterday's jam. Two Titans Crowned in Poker Showdown The action wrapped up with a jaw-dropping $6,862,500 prize pool....

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 92

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Beta Bionics Class Action: Critical Investor Alert

Updated Category News Views 27

An Investor's Wake-Up Call: Beta Bionics Lawsuit Folks, if you've got skin in the game with Beta Bionics (NASDAQ: BBNX), there's a storm on the horizon. We're talking big legal guns out and aimed at Beta Bionics with that class action suit looming. If you sunk some serious dough between July 30, 2025, and February 24, 2026, it's time to shake up and assess your losses....

Continue Reading
Howard Hughes Joins S&P SmallCap 600, Arcosa Out

Updated Category News Views 45

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...

Continue Reading
Bay Area to Host New Jerry Garcia Arts Center

Updated Category News Views 43

Celebrating a Legend in the Heart of San Francisco The Bay Area is set to become home to a vibrant new center dedicated to celebrating the multifaceted legacy of Jerry Garcia, Grateful Dead co-founder. Announced by the Garcia family, with the help of archival platform Starchive and project coordinator Christopher McCutcheon, the Jerry Garcia Music Arts Center promises to...

Continue Reading
Palmstreet Amplifies Designer Toys at Las Vegas Con

Updated Category News Views 9

Designer Toys Take the Spotlight Palmstreet's latest move into the designer toy world is buzzing with anticipation. This live-shopping app, initially catering to rare plants, is taking its evolution seriously with another plunge into exclusive collectibles, this time showcasing unique collaborations at DesignerCon in Las Vegas. While Palmstreet may have started in a...

Continue Reading
Estrogen Patch Struggles: Menopause Care Needs a Boost

Updated Category News Views 25

Troublesome Estrogen Patch Shortages Hit Hard You'd think getting a prescription filled would be a simple task, right? Well, think again. Midi Health shines a glaring light on how the supposed ease of getting hormone therapy is anything but for many women in 2026. Out of those scrambling for estradiol patches, 44% hit roadblocks in pharmacies, and a third hit an all-out...

Continue Reading

Top 5 Most Recently Viewed Articles

Barclays Strengthens Industrials Banking with New Leadership Team

Updated Category News Views 412

Barclays Enhances Industrials Banking with New Leadership Team Barclays has recently made important additions to its Industrials Investment Banking team. The new appointments include Derek McNulty, who will serve as Global Co-Head of Chemicals Investment Banking; Derek Davidson, who is now the Head of Americas Commercial, Residential and Industrials Services; and Jared...

Continue Reading
Chery's LEPAS L8 Launch: A New Era of Elegant Mobility

Updated Category News Views 667

Chery's LEPAS Brand Debuts with L8 Vehicle Release Chery has recently taken a significant step in its global strategy with the introduction of a brand-new venture named LEPAS. This initiative proudly presents its first model, the LEPAS L8, which debuted with a striking and sophisticated design. Chery's strategic positioning of LEPAS accomplishes a challenge in the market...

Continue Reading
Investors Alerted: Potential Breach of Duty at Five9, Inc.

Updated Category News Views 310

Why This Matters to Shareholders When a company starts showing cracks, the alarm bells should ring loudly for investors. Five9, Inc. has landed in hot water, and it’s not just about a few missed targets. Kuehn Law is on the hunt, investigating whether the bigwigs at Five9 failed to uphold their fiduciary duties. This isn’t your average Tuesday in the stock market;...

Continue Reading
Unveiling TokenWERX™: Innovations in Digital Infrastructure

Updated Category News Views 231

Tokenova Launches TokenWERX™: A New Era in Digital Infrastructure A Florida-led initiative is on the rise, connecting verified data, compliant capital, and fostering global collaboration through strategic partnerships with innovators such as LaunchWERX and various networks. Today, Tokenova, Inc. is proud to announce the unveiling of TokenWERX™, a groundbreaking...

Continue Reading
Aquaporin's Q1 2025 Statement: Financial Progress and Strategy

Updated Category News Views 210

Aquaporin's Trading Statement for Q1 2025 Company Announcement No. 08/2025 Aquaporin A/S Nymøllevej 78 DK-2800 Kongens Lyngby aquaporin.com Company registration no.: DK28315694 KONGENS LYNGBY, Denmark — Aquaporin A/S (CSE: AQP), a pioneering water technology company focused on innovative water filtration through biotechnology, announces its Q1 2025 Trading Statement...

Continue Reading